Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-24

Clinical Trial Update: Evaluation of Oral Corticosteroid Therapy in Idiopathic Sudden Unilateral Hearing Loss. [Phase 3]

View source ↗

Summary

This document describes a Phase 3 clinical trial evaluating oral corticosteroid therapy for idiopathic sudden unilateral hearing loss. The study is currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral corticosteroid therapy

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Sudden Sensorineural Hearing Loss | Phase 3 | Status: NOT_YET_RECRUITING